"Juzentaihoto" for fatigue of patients with solid cancer Observational study of feasibility and safety

"Juzentaihoto" for fatigue of patients with solid cancer Observational study of feasibility and safety - Study of feasibility and safety"Juzentaihoto" for fatigue of patients with solid cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028094

Enrollment

Registered

2017-07-06

Start date

2016-10-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fatigue in solid cancer patients

Interventions

juzentaihoto

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Those who complain of fatigue in cancer patients 20 to 75 years old 2)Those who have been confirmed normal liver-kidney function, normal potassium values by blood test, and normal blood pressure in advance 3)Those who obtained document consent by the patient's free will after sufficient informed consent to participate in this research

Exclusion criteria

Exclusion criteria: 1)Those who have taken Kampo formula within the last 2 weeks 2)Women who are pregnant or breast feeding 3)Person who has history of hypersensitivity to juzentaihoto 4)In case the research practitioner determines that it is inappropriate

Design outcomes

Primary

Measure	Time frame
Feasibility of juzentaihoto of cancer patients	—

Countries

Japan

Contacts

Public ContactKeiko Ogawa

Kanazawa University Hospital Department of Japanese-Traditional (Kampo) Medicine

okeiko@med.kanazawa-u.ac.jp076-265-2918

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026

&quot;Juzentaihoto&quot; for fatigue of patients with solid cancer Observational study of feasibility and safety